Sundial: Analysts Expect Positive EBITDA For Q3 2021

Sundial Growers (NASDAQ: SNDL) announced that they will be reporting their third quarter financials after the markets close on November 10th.

Analysts have a consensus US$0.71 12-month price target on the company, via a total of 5 analysts, with 4 analysts having hold ratings, and one other analyst has a sell rating on the company. The street high comes from ATB Capital Markets with a US$0.80 price target, and the lowest target comes from Cantor Fitzgerald with a US$0.00 price target.

Only 4 analysts have revenue estimates for the third quarter. The mean between all 4 is C$16.48 million; this number has been remained flat since the start of May. The street high is C$19.1 million while the lowest sits at C$11.40 million.

Only two analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 35.3%, with this number being flat at the start of May. Street high is a 40.6% estimate and the lowest sits at 30%.

Onto EBITDA estimates, there are currently only 3 analysts who have third-quarter EBITDA estimates. The mean is currently C$0.97 million, with this number being slightly higher than at the start of May. Street high sits at C$2 million EBITDA and the lowest being a (C$0.4) million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold & Copper Stocks Everyone Keeps Asking About | Oct. 12-16 – Weekly Mining Mailbag

Similar Gold Mines Are Valued 10X Higher. Why Not This One? | JW Dumont – Granada Gold Mine

The US Interest Bill Gold Can’t Ignore | Peter Grandich

Recommended

Cambria’s Silver Coin Infill Program Delivers 98.56 g/t Gold Over 8.2 Metres

First Majestic Produces 3.4 Million Ounces of Silver in Q3 2026, Jerritt Canyon Restart Remains on Track

Related News

Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target

Recently, Canaccord Genuity’s Tania Gonsalves initiated coverage on Antibe Therapeutics (TSXV: ATE), a biotechnology company...

Tuesday, August 18, 2020, 01:46:28 PM

Haywood: TPCO Is “A Formidable California Cannabis Company with Unparalleled Consumer Reach”

Just two weeks after the de-SPACing of TPCO Holdings Corp (NEO: GRAM.u) (OTC: GRAMF), which...

Friday, January 29, 2021, 04:03:00 PM

Green Thumb Sees Consensus Estimate Fall To $49.89 After Q4 Earnings

Earlier this week, Green Thumb Industries (CSE: GTII) reported its fourth quarter financial results. The...

Thursday, March 3, 2022, 04:31:00 PM

BMO Forecasts Bleak Results For Micron Technology

Micron Technology (NASDAQ: MU) is expected to report its fiscal fourth quarter results on September...

Saturday, September 24, 2022, 03:31:00 PM

Canopy Growth: Cowen & Co Slashes Price Target To $16

On November 5th, Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) reported their fiscal second quarter...

Thursday, November 11, 2021, 04:50:00 PM